Next, they expanded their study by using polyclonal anti-Lcn-2 antibodies in an aggressive mouse 4T1-induced mammary tumor model and showed strong interreference with lung metastasis, yet almost no effect on the primary tumor growth [141]. Here, LCN2 is linked to breast cancer.